These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 5846008)
1. Effect of vasopressor drugs on circulatory dynamics in shock following myocardial infarction. Binder MJ Am J Cardiol; 1965 Dec; 16(6):834-40. PubMed ID: 5846008 [No Abstract] [Full Text] [Related]
2. Studies in clinical shock and hypotension. 3. Comparative effects of vasopressor drugs and dextran. Cohn JN; Luria MH Arch Intern Med; 1965 Oct; 116(4):562-6. PubMed ID: 4284276 [No Abstract] [Full Text] [Related]
3. The physiologic basis for treatment of shock associated with myocardial infarction. Gunnar RM; Pietras RJ; Stavrakos C; Loeb HS; Tobin JR Med Clin North Am; 1967 Jan; 51(1):69-81. PubMed ID: 4869243 [No Abstract] [Full Text] [Related]
4. The treatment of cardiogenic shock. II. The use of pressor agents in the treatment of cardiogenic shock. Kuhn LA Am Heart J; 1967 Nov; 74(5):725-8. PubMed ID: 6055703 [No Abstract] [Full Text] [Related]
5. [Vasopressor drugs in shock due to myocardial infarction]. Adamska-Dyniewska H Pol Tyg Lek; 1967 Oct; 22(45):1744-7. PubMed ID: 4294154 [No Abstract] [Full Text] [Related]
8. Drugs for shock following acute myocardial infarction. Walters MB Can Med Assoc J; 1965 Oct; 93(17):933-4. PubMed ID: 5829411 [No Abstract] [Full Text] [Related]
9. The dilemma of vasopressors and vasodilators in the therapy of shock. Shoemaker WC; Brown RS Surg Gynecol Obstet; 1971 Jan; 132(1):51-7. PubMed ID: 5538813 [No Abstract] [Full Text] [Related]
10. Studies in clinical shock and hypotension. VII. Renal hemodynamics before and during treatment. Tristani FE; Cohn JN Circulation; 1970 Nov; 42(5):839-51. PubMed ID: 4320083 [No Abstract] [Full Text] [Related]
11. [Indications, in anesthesia and resuscitation, for various analeptics during cardiogenic shock]. Lekieffre J Anesth Analg (Paris); 1969; 26(5):723-31. PubMed ID: 4312807 [No Abstract] [Full Text] [Related]
12. [Pressor amines and cardiogenic shock. An evalution with special reference to the use of noradrenaline]. Hillestad L Tidsskr Nor Laegeforen; 1965 Nov; 85(21):1621-4. PubMed ID: 5882929 [No Abstract] [Full Text] [Related]
13. Vasodilator action of a "pressor amine," mephentermine (Wyamine), in circulatory shock. Udhoji VN; Weil MH Am J Cardiol; 1965 Dec; 16(6):841-6. PubMed ID: 5846009 [No Abstract] [Full Text] [Related]
14. Mechanisms of pressor amine dependence. Botticelli JT; Tsagaris TJ; Lange RL Am J Cardiol; 1965 Dec; 16(6):847-58. PubMed ID: 4284840 [No Abstract] [Full Text] [Related]
16. Current status of the treatment of shock complicating acute myocardial infarction. Friedberg CK J Trauma; 1969 Feb; 9(2):141-2. PubMed ID: 5763330 [No Abstract] [Full Text] [Related]
17. Ineffectiveness of isoproterenol in shock due to acute myocardial infarction. Gunnar RM; Loeb HS; Pietras RJ; Tobin JR JAMA; 1967 Dec; 202(13):1124-8. PubMed ID: 6072706 [No Abstract] [Full Text] [Related]
18. Effects of phenoxybenzamine in shock due to myocardial infarction. Riordan JF; Walters G Br Med J; 1969 Jan; 1(5637):155-8. PubMed ID: 5762277 [TBL] [Abstract][Full Text] [Related]
19. Medical tretment and mortality in cardiogenic shock. Metaraminol compared with combined phentolamine and norepinephrine. Glucagon therapy. Takkunen J; Oilinki O; Huhti E; Vuopala U; Koivisto O Acta Med Scand; 1972 Sep; 192(3):165-70. PubMed ID: 5055261 [No Abstract] [Full Text] [Related]
20. Treatment of shock following myocardial infarction. Cohn JN J Iowa Med Soc; 1969 Aug; 59(8):756-7. PubMed ID: 5402477 [No Abstract] [Full Text] [Related] [Next] [New Search]